Mueller Brian — SEC Form 4 filings
SEC reporting owner CIK 1514980. 9 Form 4 filings on record with FilingPulse; latest filed 2026-03-19.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-29 to 2026-03-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 5,000 shares, $375,950 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 5,000 shares @ $75.19 ($375,950) in BIOMARIN PHARMACEUTICAL INC, filed 2024-05-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Financial Officer | 9 | — | 1 leg · 5,000 sh · $375,950 | 23 |
Form 4 filings — Mueller Brian
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-19 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 2,117 @ $56.05 | EDGAR |
| 2026-03-17 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 9,945 @ $58.51 · Grant/award (A): 18,740 @ $0 · Grant/award (A): 44,600 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 6,683 @ $0 · Grant/award (A): 7,230 @ $0 · Grant/award (A): 2,569 @ $0 | EDGAR |
| 2025-03-18 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 18,497 @ $69.44 · Grant/award (A): 16,640 @ $0 · Grant/award (A): 38,590 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 11,040 @ $0 · Grant/award (A): 9,660 @ $0 · Grant/award (A): 9,367 @ $0 | EDGAR |
| 2024-07-01 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 588 @ $82.33 | EDGAR |
| 2024-05-31 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 300 @ $68.65 · Option exercise (M): 5,000 @ $63.10 · Sale (S): 5,000 @ $75.19 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 11,400 @ $0 · Tax withholding (F): 20,789 @ $83.87 · Grant/award (A): 25,540 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 20,220 @ $0 · Grant/award (A): 8,802 @ $0 · Grant/award (A): 6,103 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1514980 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →